Department of Surgery, College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue, Suite 820, New York, NY 10032-3784, USA.
J Gastrointest Surg. 2010 Nov;14(11):1838-46. doi: 10.1007/s11605-010-1345-1. Epub 2010 Sep 8.
Surgery offers the only chance for cure in patients with pancreatic cancer, and a growing number of elderly patients are being offered resection. We examined outcomes after pancreaticoduodenectomy in patients 80 years and older.
We retrospectively collected data on pancreaticoduodenectomy patients from 1992 to 2009 to compare outcomes between patients older and younger than 80 years. Variables were compared using t-, Wilcoxon rank-sum, or Fisher's exact tests. Survival was compared using Kaplan-Meier analysis and log-rank test.
Patients 80 years and older who underwent pancreaticoduodenectomy were similar with respect to sex, race, blood loss, operative times, reoperation, length of stay, and readmission compared to younger patients. There were no differences in overall complications (47% vs. 51%, p = 0.54), major complications (19% vs. 25%, p = 0.25), and mortality (5% vs. 4%, p = 0.53) when comparing older to younger patients. In a subset who underwent pancreaticoduodenectomy for ductal adenocarcinoma, older patients (n = 45) had a median survival time of 11.6 months compared to 18.1 months in younger patients (n = 346; p < 0.01).
Pancreaticoduodenectomy can be performed safely in select patients 80 years and older. Age alone should not dissuade surgeons from offering patients resection, though elderly patients with pancreatic ductal adenocarcinoma appear to have shorter survival than younger patients with the same disease.
手术是胰腺癌患者治愈的唯一机会,越来越多的老年患者被建议进行切除术。我们研究了 80 岁及以上患者行胰十二指肠切除术的结果。
我们回顾性收集了 1992 年至 2009 年胰十二指肠切除术患者的数据,比较了 80 岁以上和 80 岁以下患者的结果。使用 t 检验、Wilcoxon 秩和检验或 Fisher 确切检验比较变量。使用 Kaplan-Meier 分析和对数秩检验比较生存情况。
与年轻患者相比,80 岁及以上行胰十二指肠切除术的患者在性别、种族、出血量、手术时间、再次手术、住院时间和再入院方面相似。总体并发症(47% vs. 51%,p = 0.54)、主要并发症(19% vs. 25%,p = 0.25)和死亡率(5% vs. 4%,p = 0.53)无差异。在接受胰十二指肠切除术治疗导管腺癌的亚组中,老年患者(n = 45)的中位生存时间为 11.6 个月,而年轻患者(n = 346)为 18.1 个月(p < 0.01)。
在选择的 80 岁及以上患者中,可以安全地进行胰十二指肠切除术。仅年龄不应劝阻外科医生为患者提供切除术,尽管患有相同疾病的老年胰腺导管腺癌患者的生存时间似乎比年轻患者短。